Literature DB >> 11023295

Hepatitis C virus infection associated with B-cell non-Hodgkin's lymphoma in Hungarian patients.

B Gasztonyi, A Pár, A Szomor, I Battyány, A Nagy, L Kereskai, H Losonczy, G Mózsik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11023295

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes.

Authors:  Lenka Goldman; Sameera Ezzat; Nadia Mokhtar; Amany Abdel-Hamid; Nathan Fowler; Iman Gouda; Soheir Abdel Latif Eissa; Mohamed Abdel-Hamid; Christopher A Loffredo
Journal:  Cancer Causes Control       Date:  2009-03-05       Impact factor: 2.506

2.  HCV and HGV infection in Hodgkin's disease.

Authors:  Katalin Keresztes; Mária Takács; Margit Horányi; Zsófia Miltényi; Arpád Illés
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

Review 3.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

4.  Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.

Authors:  M Ozguroglu; A Bilici; H Turna; S Serdengecti
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

5.  Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.

Authors:  Shih-Feng Cho; Yi-Hsin Yang; Yi-Chang Liu; Hui-Hua Hsiao; Chiung-Tang Huang; Cheng-Han Wu; Yu-Fen Tsai; Hui-Ching Wang; Ta-Chih Liu
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.